Introduced
by
To impose new rules and restrictions on health insurers and pharmacy benefit managers in selling and marketing prescription drugs to certain hospitals and medical service providers who are eligible for discounts under a federal law.
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Ways and Means.
Referred to the Committee on Ways and Means
